Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0851409
Disease: Glaucoma and ocular hypertension
Glaucoma and ocular hypertension
0.010 Biomarker disease BEFREE Omidenepag isopropyl is a selective prostaglandin EP2 receptor agonist which was approved on September 21, 2018, in Japan for the treatment of glaucoma and OHT. 31250842 2019